BioNano (BNGO) Stock
Fundamentals
Latest news
About BioNano
Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano’s Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools. Bionano provides genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Albert A. Luderer Ph.D. | Chairman, Interim CEO, Interim President & Interim Principal Financial Officer | 1949 |
| Mr. Mark Oldakowski | Chief Operating Officer | 1974 |
| Mr. Mark Adamchak CPA | VP of Accounting, Principal Accounting Officer & Controller | 1981 |
| Dr. Alex Hastie Ph.D. | Chief Scientific Officer | — |
| Mr. Jonathan Dixon J.D. | General Counsel & Secretary | 1976 |
| Mr. Cory Kreeck | Global Head of People Operations | — |



